Traduction de «year the underlying » (Néerlandais → Français) :

Full year The underlying double-digit expansion in Pharmaceuticals, ranked as one of the industry’s fastestgrowing businesses based on market share, led the Group’s healthcare portfolio in 2009 to another year of record results.
Exercice complet L’expansion sous-jacente à deux chiffres de Pharmaceuticals, considérée comme l’une des entreprises connaissant la croissance la plus rapide du secteur en termes de parts de marché, a, en 2009, conduit le portefeuille des soins de santé du Groupe à enregistrer une nouvelle année de résultats records.

Spontaneous cessation rate: 2.5% OR counselling only: 1.73 Incremental OR NRT gum (relative to counselling only): 1.63 Incremental OR NRT patch (relative to counselling only): 1.79 Incremental OR NRT spray (relative to counselling only): 2.35 Incremental OR NRT inhaler (relative to counselling only): 2.14 Incremental OR bupropion (relative to counselling only): 2.30 % of smokers still under treatment after the first month: 50% (range 40-60% in sensitivity analysis) % of smokers still under treatment after the second month: 20% (range 15-25% in sensitivity analysis) Lifetime relapse probability after one year of abstinence: 35% (range 10-50% in sensitivity analysis) Effect of smoking cessation on mortality derived from the results of the American Cancer Society Prevention Study II. The mortality rate for former smokers was projected by calculating a weighted average of the incremental differentials between mortality rates of neversmokers and smokers, weighted according to the duration of abstinence.
Spontaneous cessation rate: 2.5% OR counselling only: 1.73 Incremental OR NRT gum (relative to counselling only): 1.63 Incremental OR NRT patch (relative to counselling only): 1.79 Incremental OR NRT spray (relative to counselling only): 2.35 Incremental OR NRT inhaler (relative to counselling only): 2.14 Incremental OR Buproprion (relative to counselling only): 2.30 % of smokers still under treatment after the first month: 50% (range 40-60% in sensitivity analysis) % of smokers still under treatment after the second month: 20% (range 15-25% in sensitivity analysis) Lifetime relapse probability after one year of abstinence: 35% (range 10-50% in sensitivity analysis) Effect of smoking cessation on mortality derived from the results of the American Cancer Society Prevention Study II. The mortality rate for former smokers was projected by calculating a weighted average of the incremental differentials between mortality rates of neversmokers and smokers, weighted according to the duration of abstinence.

Full-year core income from associated companies rose 25% to USD 1.1 billion on increased underlying contributions from Roche as well as full-year equity accounting of the 25% Alcon stake after the mid-2008 purchase.
Le résultat «core» de l’exercice entier provenant des entreprises associées a progressé de 25% à USD 1,1 milliard grâce à une hausse des contributions sous-jacentes de Roche et à la première comptabilisation dans les capitaux propres de la participation de 25% dans Alcon sur un exercice entier après son acquisition à la mi-2008.

Under the terms of the CIA, which has a fixed term of five years, NPC will implement additional compliance-related measures.
Selon les termes du CIA, dont la période a été fixée à cinq ans, NPC mettra en place des mesures additionnelles de mise en conformité.

We expect record full-year underlying results based on the significant progress to date in 2009”.
Grâce à la progression importante réalisée à ce jour, nous nous attendons à dégager des résultats sous-jacents records en 2009».

Other single-pill combinations in development are a combination of aliskiren and amlodipine, currently under regulatory review in the US and Europe, and a triple-combination therapy with aliskiren, amlodipine and a diuretic, expected to be submitted for US regulatory approval this year.
D’autres médicaments combinés en un comprimé unique sont en développement, tels que aliskirène et amlodipine, actuellement en cours d’examen aux Etats-Unis et en Europe, et une trithérapie avec aliskirène, amlodipine et un diurétique qu’il est prévu de soumettre cette année pour homologation aux Etats-Unis.

Amongst the under 20 year-olds, it is the fourth cause of death, all causes of death taken together, and the second external cause of death (after road accidents).
Chez les moins de 20 ans, c’est la 4 e cause de décès toutes causes confondues et la 2 e cause de décès externe (après les accidents de la circulation).

“Comparative cost analysis: Community based services as an alternative to institutions" , tender no. VT/2005/021, Official Journal on 22 June 2005 N° 2005/S 119-117014 [http ...]
K. ; Paul R (Hrsg.) : Health Promoting Hospitals in Practice: Developing Projects and Networks – Conrad, Gamburg Inclusion Europe, Included in Society (2003-2004), projet réalisé dans le contexte du Fonds social européen ( [http ...]

If your income does not exceed Euro 11,844.84 gross per year (ceiling of application in November 2012), then there are no dues under the system of compulsory insurance.
Si ceux-ci ne dépassent pas 11 844,84 euros bruts par an (plafond d’application en novembre 2012), il s’agit d’une cotisation gratuite en assurance obligatoire.

Vaccination Vaccination/adverse vaccinatie Vaccination effect Under 18 years Infant, child, Beneden 18 jaar Moins de 18 adolescent ans Epinephrine Epinephrine Adrenaline Adrenaline Prevention Accident Prevention Treatment Therapeutics Behandeling Traitement * MeSH (Medical Subject Headings) is the NLM controlled vocabulary thesaurus used for indexing articles for PubMed.
Vaccination Vaccination/adverse Vaccinatie Vaccination effect Under 18 years Infant,Child, Beneden 18 jaar Moins de 18 Adolescent ans Epinephrine Epinephrine Adrenaline Adrenaline CPR Cardiopulmonary Reanimatie Réanimation Resuscitation Prevention Accident Prevention Preventie Prévention Treatment Therapeutics Behandeling Traitement * MeSH (Medical Subject Headings) is the NLM controlled vocabulary thesaurus used for indexing articles for PubMed.